Mapping of resection margins of oral cancer for p53 overexpression and chromosome instability to detect residual (pre)maligant cells. by van der Toorn, P.P. et al.
  
 
Mapping of resection margins of oral cancer for p53
overexpression and chromosome instability to detect
residual (pre)maligant cells.
Citation for published version (APA):
van der Toorn, P. P., Veltman, J. A., Bot, F. J., de Jong, J. M. A., Manni, J. J., Ramaekers, F. C. S., &
Hopman, A. H. N. (2001). Mapping of resection margins of oral cancer for p53 overexpression and
chromosome instability to detect residual (pre)maligant cells. Journal of Pathology, 193, 66-72. 3.0.CO;2-
J" class="link">https://doi.org/10.1002/1096-9896(2000)9999:99993.0.CO;2-J
Document status and date:
Published: 01/01/2001
DOI:
10.1002/1096-9896(2000)9999:9999<::AID-PATH785>3.0.CO;2-J
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
Original Paper
Mapping of resection margins of oral cancer for p53
overexpression and chromosome instability to detect
residual (pre)malignant cells
Peter-Paul G. van der Toorn1, Joris A. Veltman2, Fredrik J. Bot3, Joseph M. A. de Jong1, Johannes J. Manni2*,
Frans C. S. Ramaekers4 and Anton H. N. Hopman4
1 Radiotherapeutic Institute, Limburg, The Netherlands
2 Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Maastricht, The Netherlands
3 Department of Pathology, University Hospital Maastricht, The Netherlands
4 Department of Molecular Cell Biology and Genetics, University of Maastricht, The Netherlands
*Correspondence to:
Johannes J. Manni, Department
of Otorhinolaryngology and
Head and Neck Surgery,
University Hospital Maastricht,
PO Box 5800, 6202 AZ
Maastricht, The Netherlands.
E-mail: J.J.Manni@kno.azm.nl
Received: 15 May 2000
Accepted: 8 August 2000
Published online:
16 November 2000
Abstract
Oral squamous cell cancers (OSCCs) have a high local recurrence rate, partly due to problems in
the recognition of minimal residual disease. The use of molecular markers is shown to increase the
sensitivity of detection of residual malignant cells in tumour margins of OSCC. p53
immunohistochemistry was combined with in situ hybridization for chromosomes 1 and 7 to
determine the presence of genetically unstable cells in resection specimens of OSCC containing
invasive cancer. An increased frequency of genetically aberrant cells was observed, as detected by
p53 overexpression and/or aneusomy, with histological progression of normal mucosa via
hyperplasia to dysplasia. Of clinical importance was the finding that 11 of 20 resection margins,
all of which were initially diagnosed as being tumour-free, were found to contain genetically
aberrant (pre)malignant cells. In these areas, closer histological examination of the genetically
aberrant compartment within these margins often also revealed small dysplastic areas that were
missed in the initial diagnosis, showing that this genetic approach can assist in diagnosis.
Copyright # 2000 John Wiley & Sons, Ltd.
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Introduction
The acquisition of genetic instability is an essential step
during carcinogenesis [1,2]. In most tumours, including
oral squamous cell carcinomas (OSCCs), such a
genomic change results in numerical and structural
chromosome alterations [3,4]. Although the molecular
basis of this chromosomal instability is as yet
unknown, it has been suggested that mutations in one
or more mitotic checkpoint genes cause abnormal cell
division, leading to an abnormal chromosome consti-
tution [5]. One of the candidate genes is p53, being one
of the most frequently altered tumour suppressor genes
known to date [6,7]. Several studies have suggested
that loss of normal p53 function leads to destabiliza-
tion of the genome and facilitates the development of
DNA aneuploidy [8,9]. This would suggest that
mutations of p53, which can be detected immunocyto-
chemically because of its stabilization, precede the
acquisition of chromosomal alterations. On the other
hand, there are also indications that genetic instability
can lead to loss of tumour suppressor genes such as
p53 in solid cancers [10], indicating that the relation-
ship between the two processes is still unclear. It has
been shown that both p53 immunoreactivity and
numerical chromosome alterations can be detected in
premalignant stages of head and neck carcinogenesis
[11–15], but again in these early lesions the two
processes have not as yet been correlated.
In the present study, we have therefore combined
p53 immunohistochemistry with chromosome in situ
hybridization for the detection of numerical aberra-
tions of chromosomes 1 and 7 in the subsequent steps
of oral carcinogenesis. These chromosomes were
selected on the basis of previous studies on head and
neck squamous cell carcinoma (HNSCC) [4,14–16].
The correlation between the two processes was studied
in resection specimens of OSCC containing invasive
cancer, precursor lesions, and histologically normal
mucosa.
From a clinical point of view, these markers of
genetic instability may be useful for detecting the
presence of minimal residual disease. It is generally
believed that the presence of (pre)malignant cells in a
resection margin constitutes a high risk for local
recurrence, one of the major problems in head and
neck oncology [17–19]. The histopathological features
of premalignant lesions, which might be present within
the resection margin, are very subtle and consequently,
the interpretation of these features is subjective [20]. In
contrast, direct visualization of genetic changes in
tissue sections by either immunohistochemistry or in
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situ hybridization gives objective information on the
extent of genetic damage present within these margins,
and might therefore be of value in diagnosis.
Materials and methods
Patient material
Formalin-fixed, paraffin-embedded tumour specimens
were obtained from 21 patients with radically resected
(resection margin>5 mm free of invasive carcinoma)
squamous cell carcinoma of the tongue, diagnosed
between 1995 and 1997. All patients had a history of
smoking and drinking. Patients were treated by surgery
only and classified as pT1N0M0 (n=13), pT2N0M0
(n=7), and pT3N0M0 (n=1) (UICC, 1987). From
these 21 patients a specimen representative of the free
resection margin was selected after reviewing the
original haematoxylin and eosin (H&E)-stained sec-
tions. In six cases, resection margin samples also
contained OSCC. Of the remaining 15 patients, seven
additional OSCC specimens were selected. As a result,
a total of 28 specimens were studied, 15 containing a
free margin only and 13 containing both tumour and
adjacent epithelium. As a control group, four patients
with a benign lesion of the tongue were included (two
hyperkeratotic papillomas and two fibromas). From all
cases, 4 mm thick sections were used for detailed
histological examination, p53 immunohistochemistry,
and chromosome in situ hybridization.
Histological examination
All specimens were H&E-stained and subsequently
reviewed by an experienced pathologist (FJB). Normal,
hyperplastic, dysplastic, carcinoma in situ (CIS), and
tumour areas, if present, were identified and marked
on the slide for detailed comparisons with the genetic
data. The classification of hyperplasia, mild, moderate
and severe dysplasia/carcinoma in situ, or infiltrative
carcinoma was undertaken as follows. Hyperplasia is
defined as keratosis and acanthosis with at most slight
atypia of the basal cell layer. Dysplasia shows, in
addition, more than just slight individual cell atypia,
increasing keratosis and sometimes parakeratosis. This
group could be subdivided into mild and moderate
dysplasia, but the cases were considered as a single
group, for reasons of simplicity; this is clinically
justified, because mild and moderate dysplasia would
not lead to therapeutic intervention, but only follow-
up, while severe dysplasia/carcinoma in situ definitely
would. Severe dysplasia/carcinoma in situ is character-
ized by increasing, often full thickness cell atypia, loss
of polarity, and frequent mitoses, while lacking
infiltrative growth. Carcinoma is then defined as
showing infiltrative growth with an accompanying
stromal reaction. Normal epithelium is regular non-
keratinizing squamous epithelium without the features
mentioned above. In all cases, the changes described
refer to abnormalities involving the complete epithelial
cell layer. Small areas of atypical cells do not fit into
this classification.
In addition to the standard histological examination
performed at the beginning of this study, a detailed
histological examination was performed after the
chromosome in situ hybridization and p53 analyses
were completed, and all tissue areas containing genetic
abnormalities had been precisely mapped. During re-
examination, the pathologist focused on the areas
containing genetic abnormalities. These regions were
often very small, consisting in some cases of no more
than 10–20 cells.
In situ hybridization
In situ hybridization (ISH) was essentially performed
using a recently optimized protocol and evaluated
according to well-established criteria [21,22]. Briefly,
after deparaffinization, the 4 mm thick sections were
pretreated with 85% formic acid containing 0.3%
H2O2, followed by incubation at 80uC in 1 M sodium
thiocyanate. After digestion with pepsin (4 mg/ml in
0.02 N HCl), individual sections were hybridized with a
centromere-specific probe for either chromosome 1 or
chromosome 7 [23], labelled with biotin-11-dUTP
(Boehringer, Mannheim, Germany). Immunocyto-
chemical detection of hybrids was performed by the
standard avidin–biotin complex (ABC) procedure
(Vectastain, Vector Laboratories, Burlingame, CA,
USA). Peroxidase activity was detected using diamino-
benzidine (DAB)/H2O2. Sections were counterstained
with haematoxylin and mounted in Entellan (Merck,
Darmstadt, Germany). Evaluation was performed
qualitatively by independent detailed analys is of the
complete epithelium by two of us (PPGvdT and JAV).
The sections were analysed to identify whether nuclei
containing aberrant chromosome copy numbers were
present. Histologically described epithelial areas were
classified as either disomic (normal), when no nuclei
with three or more ISH signals were observed, or
aneusomic (abnormal), when multiple nuclei with three
or more ISH signals were present for one or both
chromosomes.
p53 immunohistochemistry
An immunohistochemical assessment of p53 protein
overexpression was performed on 4 mm sections from
paraffin-embedded tissue. After deparaffinization, the
sections were pretreated with 0.3% H2O2 in methanol
to quench endogenous peroxidase activity. Antigen
retrieval was performed by microwave heating in
0.01 M citrate buffer (pH 6.0). Both normal and
mutant p53 protein were detected using a monoclonal
antibody (clone DO-7; DAKO A/S, Glostrup, Den-
mark). After incubation with the biotinylated second-
ary antibody, immunochemical detection was further
performed as described for the in situ hybridization. In
each analysis, a known p53-negative and p53-positive
oropharyngeal tumour served as a control. Evaluation
of the complete lesion was performed qualitatively by
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three of us (PPGvdT, JAV, and FJB). Histologically
described epithelial areas were classified as either p53
negative, when no or only a few cells with positive
nuclear staining were observed, or p53-positive, when
multiple cells with positive nuclear staining were
present.
Results
Histological re-examination guided by genetic
analysis
Both p53 immunohistochemistry and chromosome
ISH could be evaluated from the tissue sections of 20
out of 21 patients (95%) with OSCC and in all control
patients. In the control group, neither cells showing
p53 overexpression, nor cells containing abnormal
copy numbers of chromosomes 1 and 7 were detected
after detailed analysis of the complete epithelium. p53
overexpression and abnormal chromosome copy num-
bers were detected frequently in the resection speci-
mens, often in small foci which sometimes consisted of
no more than 10–20 cells, located within areas that
were initially diagnosed as normal or hyperplastic. For
this reason, the specimens were re-examined histologi-
cally, with a special focus on the genetically aberrant
tissue compartments, in contrast to the results from the
initial histological examination, in which dysplasia was
identified in only three samples, re-examination
revealed dysplasia in 14 samples.
Correlation between histology, genotype, and
p53 status
Table 1 summarizes in detail the results for p53
immunohistochemical staining and chromosome ISH
for each of the 20 patients with OSCC. Results for
chromosomes 1 and 7 are combined in this table. As a
typical example, the resection margin of case 10
contains histologically normal, hyperplastic, and dys-
plastic areas, whereas an additional sample of the same
case contains the carcinoma adjacent to regions with
hyperplasia and dysplasia. The normal and the
hyperplastic regions are genetically normal, with no
p53 overexpression and no nuclei with more than two
copies of chromosomes 1 and 7, whereas the dysplastic
areas and the carcinoma region show both p53 over-
expression and abnormal chromosome copy numbers.
In some other cases, the relationship between histol-
ogy, p53 overexpression, and the presence of chromo-
somal alterations is less clear. For example, in case 19,
p53 overexpression is present in a hyperplastic area
without chromosomal abnormalities. In contrast, the
carcinoma region of this case contains numerical
aberrations for both chromosomes, but does not
show p53 overexpression.
Figure 1 illustrates typical p53 staining and ISH
results in the OSCC and in part of the resection margin
of case 16. As can be seen in this figure, the tumour
cells are p53-positive and contain multiple copies of
chromosome 7. In part of the resection margin,
histologically classified as hyperplasia, a distinct area
with p53 overexpression and chromosome abnormal-
ities was detected immediately adjacent to a (histolo-
gically identical) area without these genetic changes.
Interestingly, in this case, the area with hyperplasia
contained a maximum number of three ISH signals
(indicating trisomy) for chromosome 1 and four ISH
signals (indicating tetrasomy) for chromosome 7. In
contrast, the tumour area showed a maximum number
of six ISH signals (hexasomy) for chromosome 1 and
eight ISH signals (octasomy) for chromosome 7. These
data suggest that endoreduplication has occurred in
the transition from hyperplasia to invasive SCC.
In total, seven out of 20 OSCC patients showed both
p53 overexpression and numerical chromosomal aber-
rations in the resection margin. In four patients, either
p53 overexpression or chromosomal alterations were
detected in the resection margin, whereas the resection
margin of the remaining nine patients did not show
abnormalities with either technique.
Table 1. Results of the p53 and ISH analyses of 20
patients with OSCC
Histological classification
Patient
Normal Hyperplasia Dysplasia CIS/OSCC
No. p53 ISH p53 ISH p53 ISH p53 ISH
1 N N N N – – – –
2 – – N N – – – –
3 – – N N – – – –
4 – – N N – – N N
5a N N – – – – – –
b N N N N – – N N
6 N N – – – – N A
7a N N – – – – – –
b N N N N N N N A
8a N N – – – – – –
b N N – – – – A A
9a – – N N A A – –
b – – N N A A A A
10a N N N N A A – –
b – – N N A A A A
11a N N N N A A – –
b – – – – A A A A
12 – – N N A N – –
13 – – N N A A – –
14 – – – – N A N A
15a N N – – – – – –
b N N A A – – A A
16 N N A A A A A A
17 – – N A – – – –
18 – – A N A A – –
19 – – A N – – N A
20 N N A N – – A A
CIS=carcinoma in situ; OSCC=oral squamous cell carcinoma; ISH=in situ
hybridization.
a, b: In seven cases, two samples taken from different locations were
analysed. In these cases, sample ‘a’ contains the margin of resection and
sample ‘b’ contains the tumour and adjacent mucosa.
N: classified as normal (p53-negative/ISH disomic); A: classified as abnormal
(p53 overexpression/ISH showing abnormal chromosome copy numbers).
For histological classification see the Materials and methods section.
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Figure 1. Histology, p53 immunohistochemistry, and ISH analysis of the OSCC (A–C) and its resection margin (D–L) in case 16.
(A–C) H&E analysis of the OSCC (A), with p53 immunostaining (B) and ISH with a probe for chromosome 7 (C). The tumour cells
are clearly overexpressing p53 and contain multiple copies (with a maximal copy number of 8) for chromosome 7. (D–L) H&E
analysis of the resection margin (overview in D; details in F and G), by p53 immunohistochemistry (overview in E; details in H and I),
and ISH with a probe for chromosome 7 of the corresponding area (J, K, L). This part of the resection margin was classified as
hyperplastic but shows both overexpression of p53 and numerical aberrations for chromosome 7 in part of the epithelium (in this
case, with a maximal copy number of 4), whereas an adjacent part is negative for p53 staining and contains no numerical
chromosome aberrations. Note that the area showing p53 overexpression perfectly matches the area containing chromosome
aberrations
Genetic changes in resection margins of tongue cancer 69
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Figure 2 shows the correlation between p53 over-
expression and abnormal chromosome copy number
with regard to the different histological areas present in
the various samples of all 20 patients. As can be seen in
this figure, neither p53 overexpression nor chromoso-
mal abnormalities were detected in tissue compart-
ments consisting of histologically normal epithelium. A
low percentage of hyperplastic tissue compartments
showed p53 overexpression and/or chromosomal
abnormalities. In contrast, most dysplastic lesions (9
out of 12) showed both p53 overexpression and
aberrant chromosome copy numbers. Chromosomal
alterations were also present in 11 out of 13 CIS/OSCC
areas, with only seven of these areas showing p53
overexpression.
Discussion
A gap appears to exist between the histopathological
diagnosis of the resection margin of tumour specimens
and the patient’s clinical course. Depending on the
primary tumour site and stage of disease, patients with
OSCC develop locoregional recurrent disease in
15–30% of cases, even when the resection margins are
histopathologically free of tumour.
The introduction of molecular techniques to assess
the presence of malignant cells in the resection margins
can help to bridge this gap. Tumour-specific chromo-
somal aberrations or DNA mutations detected in the
primary tumour can, in principle, be used as markers
for the detection of residual cells in the resection
margins. Residual tumour cells could explain the
recurrence rate and if detected in individual cases,
could provide an indication for additional treatment.
In this study, we used p53 immunohistochemistry and
chromosome ISH to analyse in detail the resection
margins of tongue carcinomas for the presence of
genetically aberrant cells.
Genetically aberrant cells, as marked by either p53
overexpression or/and aneusomies for chromosomes 1
and 7, were identified in the resection margins from 11
of 20 OSCC patients. In seven of these 11 resection
margins, genetically aberrant cells were detected with
both techniques, which provides a strong indication for
the presence of (pre)malignant cells located in areas
close to the limit of resection. In a previous study on
premalignant laryngeal lesions, we detected numerical
aberrations of chromosomes 1 and/or 7 in 14 out of
15 dysplastic lesions, whereas only one out of 11
hyperplastic lesions showed chromosomal alterations
[15]. This finding underlines the usefulness of chromo-
somal alterations as markers for a dysplastic pheno-
type in head and neck carcinogenesis. Many authors
have claimed the detection of genetic abnormalities in
histologically normal mucosa adjacent to HNSCC
[11,13,14]. Furthermore, mutated p53 genes have been
Figure 2. Frequency histograms showing the correlation between p53 staining and the ISH classification in different stages of oral
carcinogenesis. (A) Normal tongue epithelium (n=14); (B) hyperplastic epithelium (n=19); (C) dysplastic epithelium (n=12);
(D) CIS/OSCC (n=13)
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found in tumour-distant epithelia of head and neck
cancer patients as a preceding sign of overt neoplasia
[13,24,25].
Also during this study, we frequently identified p53
overexpression and/or chromosomal aberrations in
small tissue compartments that had been classified as
normal by standard histological examination. How-
ever, after review, during which the pathologist was
guided by the genetic abnormalities in the tissue, the
morphological features of these areas urged us to
modify their classification from normal to hyperplasia,
or even dysplasia. These areas were not detected by
routine histological examination at the beginning of
our study because of their very small size, in some
cases no more than 10–20 cells. This observation
underlines the subjectivity of histological examination,
as recently discussed by, for example, Westra and
Sidransky [20].
Our data clearly show that conclusions about DNA
changes in normal mucosa can only be drawn after a
detailed histological review of the genetically aberrant
tissue compartments. During the second round of
reviewing, guided by the p53 and ISH results, aberrant
cells with cytogenetic abnormalities were detected in 11
of 20 cases, which were not recorded in the first round
of reviewing. As a consequence, these lesions were
‘upgraded’. One might argue whether upgrading in this
way, guided by results obtained from ancillary techni-
ques, is justified. In every case, only small numbers of
cells were found with the ancillary techniques. As the
classification of dysplasia relies on a mixture of cellular
atypia and architectural features, small groups like
these would not lead to upgrading in the histological
classification system, but instead would be regarded as
reactive atypia. However, they were upgraded to
dysplasia with knowledge of the ISH results for the
purposes of this study. It must be stressed that this
procedure did not result in upgrading towards high-
grade dysplasia/carcinoma in situ in any of these cases,
indicating that there were no therapeutic consequences
to be addressed following reclassification.
As a result of this in-depth histological examination
of the resection margins, a complex pattern of
histologically different areas emerged, consisting of
normal, hyperplastic, and dysplastic epithelium.
Neither the 14 areas with normal epithelium, nor the
epithelium in four control specimens, showed chromo-
somal aberrations or p53 overexpression. Chromo-
somal aberrations were detected in 16% of the
hyperplastic areas, in 77% of the dysplastic areas, and
in 88% of the CIS/OSCC areas. p53 overexpression
was detected in 26% of the hyperplastic areas, in
77% of the dysplastic areas, and in 56% of the CIS/
OSCC areas. Since the most common mechanism
for generating genetic diversity in solid tumours
involves the development of p53 abnormalities and
DNA aneuploidy [26], the correlation between p53
overexpression and the acquisition of chromosomal
abnormalities was examined. There are strong indi-
cations that these events are closely linked, although
the molecular mechanisms underlying the development
of p53-induced aneuploidy are not fully understood.
In this study, the concomitant overexpression of p53
and chromosome aneusomy detected in serial sections
showed a clear correlation between positive p53
staining and the presence of chromosomal alterations
in precisely mapped tissue compartments. This correla-
tion is most evident when the results obtained in
histologically normal epithelium are compared with
those in dysplastic tissue compartments (Figure 2A vs.
Figure 2C), which indicates that both genetic changes
take place simultaneously during the histological
transition from normal to dysplastic epithelium.
When the results for the hyperplastic epithelium
(Figure 2B), as an intermediate between normal epithe-
lium and dysplasia, are taken into consideration, the
impression is obtained that p53 overexpression pre-
cedes the occurrence of aneusomy. The finding that the
link between p53 staining and chromosome alterations
was not so evident in the group of CIS/OSCC areas
suggests that the acquisition of genetic instability is
most important in the premalignant stages of disease.
It remains to be established whether the p53 gene is
mutated in hyperplastic or dysplastic areas showing
p53 overexpression, or whether the overexpression
identified in this epithelium is merely a response of
the normal non-mutated gene to DNA damage, as
described [13].
In summary, we conclude that p53 overexpression
and the acquisition of chromosome alterations are
linked in the premalignant stages of oral carcinogen-
esis, leading to a genetic instability essential for
malignant progression. In addition, this study showed
that a combined analysis of p53 overexpression and
chromosome content gives detailed information about
the extent of genetic alterations present in precisely
mapped epithelial areas of oral resection margins.
Genetic alterations are frequently present in these
margins, even in tissue compartments that do not
show extensive histological changes. We therefore
propose that these genetic techniques might be
employed to supplement histological examination.
With ISH, the nature and extent of the aberrant cells
can be determined and correlated with standard
histology. However, since the clinical relevance of
these small groups of cytogenetically abnormal cells
in the resection margins is not clear, the data would
justify a larger prospective study, to correlate these
findings with the clinical outcome.
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